Essentially, L-Carnitine Tartrate is primarily used for improving exercise performance, while Acetyl L-Carnitine is used more for medical purposes
We can supply complete SDS, batch COA, export filing documents and regional compliance supporting materials to assist your customs clearance and brand registration in Europe and America
This is ideal if you are on the go or in a hurry in the mornings
H.KulikW.WandersR
No te conformes con cido alfa lopoico de 600 mg, 200 mg o 300 mg por porcin, la frmula Naering de 1400 mg de alta dosis es la opcin superior de suplemento de cido alfa-lipoico para ti
willd gum Substances 0.000 claims description 2 DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2 239000008272 agar Substances 0.000 claims description 2 229910052783 alkali metal Inorganic materials 0.000 claims description 2 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2 239000000686 essence Substances 0.000 claims description 2 229920000609 methyl cellulose Polymers 0.000 claims description 2 239000001923 methylcellulose Substances 0.000 claims description 2 235000010981 methylcellulose Nutrition 0.000 claims description 2 229950008882 polysorbate Drugs 0.000 claims description 2 229940085605 saccharin sodium Drugs 0.000 claims description 2 235000010413 sodium alginate Nutrition 0.000 claims description 2 239000000661 sodium alginate Substances 0.000 claims description 2 229940005550 sodium alginate Drugs 0.000 claims description 2 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2 239000008107 starch Substances 0.000 claims description 2 235000019698 starch Nutrition 0.000 claims description 2 OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 2 229940013618 stevioside Drugs 0.000 claims description 2 235000019202 steviosides Nutrition 0.000 claims description 2 229960004793 sucrose Drugs 0.000 claims description 2 230000000694 effects Effects 0.000 abstract description 8 239000004480 active ingredient Substances 0.000 abstract description 5 239000004615 ingredient Substances 0.000 abstract description 2 230000007774 longterm Effects 0.000 abstract description 2 QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract description 2 238000004321 preservation Methods 0.000 abstract description 2 SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 abstract 1 235000021355 Stearic acid Nutrition 0.000 abstract 1 229940072106 hydroxystearate Drugs 0.000 abstract 1 OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 abstract 1 239000008117 stearic acid Substances 0.000 abstract 1 XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14 150000001875 compounds Chemical class 0.000 description 11 239000000203 mixture Substances 0.000 description 11 230000001186 cumulative effect Effects 0.000 description 10 239000013078 crystal Substances 0.000 description 7 230000001954 sterilising effect Effects 0.000 description 6 238000004659 sterilization and disinfection Methods 0.000 description 6 239000003814 drug Substances 0.000 description 5 238000012546 transfer Methods 0.000 description 5 ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 4 238000002425 crystallisation Methods 0.000 description 4 230000008025 crystallization Effects 0.000 description 4 238000005516 engineering process Methods 0.000 description 4 238000002474 experimental method Methods 0.000 description 4 230000003647 oxidation Effects 0.000 description 4 238000007254 oxidation reaction Methods 0.000 description 4 239000000126 substance Substances 0.000 description 4 231100000331 toxic Toxicity 0.000 description 4 230000002588 toxic effect Effects 0.000 description 4 239000008215 water for injection Substances 0.000 description 4 CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3 206010002198 Anaphylactic reaction Diseases 0.000 description 3 RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 3 230000036783 anaphylactic response Effects 0.000 description 3 208000003455 anaphylaxis Diseases 0.000 description 3 RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 3 239000005516 coenzyme A Substances 0.000 description 3 229940093530 coenzyme a Drugs 0.000 description 3 KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 3 238000009472 formulation Methods 0.000 description 3 230000002949 hemolytic effect Effects 0.000 description 3 239000000463 material Substances 0.000 description 3 230000003381 solubilizing effect Effects 0.000 description 3 KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2 GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2 QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2 CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2 DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2 QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2 238000013459 approach Methods 0.000 description 2 210000004027 cell Anatomy 0.000 description 2 239000002552 dosage form Substances 0.000 description 2 229940079593 drug Drugs 0.000 description 2 238000001035 drying Methods 0.000 description 2 230000006870 function Effects 0.000 description 2 150000004668 long chain fatty acids Chemical class 0.000 description 2 210000003470 mitochondria Anatomy 0.000 description 2 230000002438 mitochondrial effect Effects 0.000 description 2 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2 229920000053 polysorbate 80 Polymers 0.000 description 2 239000008213 purified water Substances 0.000 description 2 230000006641 stabilisation Effects 0.000 description 2 238000011105 stabilization Methods 0.000 description 2 239000004094 surface-active agent Substances 0.000 description 2 229940088594 vitamin Drugs 0.000 description 2 229930003231 vitamin Natural products 0.000 description 2 235000013343 vitamin Nutrition 0.000 description 2 239000011782 vitamin Substances 0.000 description 2 150000003722 vitamin derivatives Chemical class 0.000 description 2 HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1 ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1 GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1 GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1 229920000858 Cyclodextrin Polymers 0.000 description 1 ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1 229920002307 Dextran Polymers 0.000 description 1 108091006149 Electron carriers Proteins 0.000 description 1 102000004190 Enzymes Human genes 0.000 description 1 108090000790 Enzymes Proteins 0.000 description 1 108030000520 Fatty-acid peroxidases Proteins 0.000 description 1 239000004471 Glycine Substances 0.000 description 1 CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1 GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1 241000124008 Mammalia Species 0.000 description 1 241001597008 Nomeidae Species 0.000 description 1 229910019142 PO4 Inorganic materials 0.000 description 1 229920002675 Polyoxyl Polymers 0.000 description 1 235000001630 Pyrus pyrifolia var culta Nutrition 0.000 description 1 240000002609 Pyrus pyrifolia var
